106 related articles for article (PubMed ID: 11574631)
1. Retrospective study of hyponatremia in gastric cancer patients treated with a combination chemotherapy of 5-fluorouracil and cisplatin: a possible warning sign of severe hematological toxicities?
Boku N; Ohtsu A; Nagashima F; Muto M; Shinkai T; Yoshida S
Jpn J Clin Oncol; 2001 Aug; 31(8):382-7. PubMed ID: 11574631
[TBL] [Abstract][Full Text] [Related]
2. [Low-dose FP therapy for advanced and recurrent gastric cancer].
Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
[TBL] [Abstract][Full Text] [Related]
3. Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapy.
Arakawa Y; Tamura M; Sakuyama T; Aiba K; Eto S; Yuda M; Tanaka Y; Matsumoto A; Nishikawa K
J Infect Chemother; 2015 Jul; 21(7):502-6. PubMed ID: 25851853
[TBL] [Abstract][Full Text] [Related]
4. Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin.
Shimada A; Takeuchi H; Fukuda K; Suda K; Nakamura R; Wada N; Kawakubo H; Kitagawa Y
Esophagus; 2018 Oct; 15(4):209-216. PubMed ID: 30225740
[TBL] [Abstract][Full Text] [Related]
5. [A randomized controlled trail of taxol-based combination regimens for advanced gastric cancer].
Yang JW; Chen YG; Chen Q; Fan NF; Guo ZQ; Cai XC; Wu XA; Xu S; Lu X; Zhang YH; Ouyang XN
Ai Zheng; 2005 Dec; 24(12):1531-6. PubMed ID: 16351808
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
[TBL] [Abstract][Full Text] [Related]
7. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
Gu Y; Shu Y; Xu Q
Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of 5-fluorouracil, pirarubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Miyakita M; Ogata Y
Jpn J Clin Oncol; 1998 May; 28(5):314-7. PubMed ID: 9703858
[TBL] [Abstract][Full Text] [Related]
10. Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis.
Numico G; Benasso M; Vannozzi MO; Merlano M; Rosso R; Viale M; Esposito M
Anticancer Res; 1998; 18(2B):1313-8. PubMed ID: 9615808
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Oyama R; Ogata Y
Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968
[TBL] [Abstract][Full Text] [Related]
12. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of docetaxel and cisplatin in patients with gastric cancer recurring after or progressing during 5-FU/platinum treatment.
Kim H; Park JH; Bang SJ; Kim DH; Cho HR; Kim GY; Min YJ
Jpn J Clin Oncol; 2005 Dec; 35(12):727-32. PubMed ID: 16332720
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501).
Nakayama N; Koizumi W; Tanabe S; Sasaki T; Saigenji K
Gastric Cancer; 2006; 9(3):185-91. PubMed ID: 16952036
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
[TBL] [Abstract][Full Text] [Related]
18. [Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport].
Shen L; Xu JM; Feng FY; Jiao SC; Wang LW; Li J; Guan ZZ; Qin SK; Wang JJ; Yu SY; Wang YJ; Jin YN; Tao M; Zheng LZ; Pan LX
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):295-300. PubMed ID: 23985260
[TBL] [Abstract][Full Text] [Related]
19. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
